↓ Skip to main content

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysis

Overview of attention for article published in Gynecologic Oncology, October 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysis
Published in
Gynecologic Oncology, October 2013
DOI 10.1016/j.ygyno.2013.10.004
Pubmed ID
Authors

Vanessa L. Beesley, Adele C. Green, David K. Wyld, Peter O’Rourke, Leesa F. Wockner, Anna deFazio, Phyllis N. Butow, Melanie A. Price, Keith R. Horwood, Alexandra M. Clavarino, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study — Quality of Life Study Investigators, Penelope M. Webb

Abstract

Most women with ovarian cancer relapse and undergo further chemotherapy however evidence regarding the benefits of this for women with platinum-resistant disease is limited. Our objective was to determine whether there was a quality of life improvement or treatment response among women treated for platinum-resistant recurrent ovarian cancer.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 20%
Student > Ph. D. Student 6 15%
Other 5 12%
Student > Postgraduate 4 10%
Student > Master 3 7%
Other 5 12%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Agricultural and Biological Sciences 3 7%
Chemistry 2 5%
Nursing and Health Professions 2 5%
Other 7 17%
Unknown 11 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2014.
All research outputs
#20,655,488
of 25,371,288 outputs
Outputs from Gynecologic Oncology
#4,231
of 4,956 outputs
Outputs of similar age
#168,979
of 223,709 outputs
Outputs of similar age from Gynecologic Oncology
#28
of 43 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,956 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,709 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.